KLK3 and prostate carcinoma: Circulating biomarkers in body fluids present advantages in the clinical diagnostic practice for the easy access as in the case of the prostate antigen (PSA, KLK3) is widely used to screen for prostate cancer while troponin (TNNT2) is a valid marker for myocardial infarction.